These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 27649986)

  • 41. Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis.
    Ferraro D; Galli V; Vitetta F; Simone AM; Bedin R; Del Giovane C; Morselli F; Filippini MM; Nichelli PF; Sola P
    J Neuroimmunol; 2015 Jun; 283():64-9. PubMed ID: 26004159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical usefulness of oligoclonal bands].
    Falip M; Tintoré M; Jardí R; Duran I; Link H; Montalbán X
    Rev Neurol; 2001 Jun 16-30; 32(12):1120-4. PubMed ID: 11562840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis.
    Fischer C; Arneth B; Koehler J; Lotz J; Lackner KJ
    Clin Chem; 2004 Oct; 50(10):1809-13. PubMed ID: 15271859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CSF testing for multiple sclerosis.
    Pender MP
    Lancet Neurol; 2005 Sep; 4(9):522-3. PubMed ID: 16109359
    [No Abstract]   [Full Text] [Related]  

  • 45. [Diagnostic value of oligoclonal band detection in cerebrospinal fluid using PhastSystem device].
    Zaborski J; Fiszer U; Kruszewska J; Korlak J; Poniatowska R; Członkowska A
    Neurol Neurochir Pol; 1994; 28(6):815-24. PubMed ID: 7870255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis.
    Duranti F; Pieri M; Centonze D; Buttari F; Bernardini S; Dessi M
    J Neuroimmunol; 2013 Oct; 263(1-2):116-20. PubMed ID: 23916392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. (University of Pennsylvania Case Conference): oligoclonal immunoglobulins in cerebrospinal fluid in multiple sclerosis.
    Keshgegian AA; Coblentz J; Lisak RP
    Clin Chem; 1980 Aug; 26(9):1340-5. PubMed ID: 7398049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebrospinal fluid oligoclonal IgG bands in patients with spinal arteriovenous malformation and structural central nervous system lesions.
    Cohen O; Biran I; Steiner I
    Arch Neurol; 2000 Apr; 57(4):553-7. PubMed ID: 10768631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis.
    Berg-Hansen P; Vandvik B; Fagerhol M; Holmøy T
    J Neuroimmunol; 2009 Nov; 216(1-2):98-102. PubMed ID: 19800696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relevance of immunological variables in neuroborreliosis and multiple sclerosis.
    Bednárová J; Stourac P; Adam P
    Acta Neurol Scand; 2005 Aug; 112(2):97-102. PubMed ID: 16008535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.
    Wuhrer M; Selman MH; McDonnell LA; Kümpfel T; Derfuss T; Khademi M; Olsson T; Hohlfeld R; Meinl E; Krumbholz M
    J Neuroinflammation; 2015 Dec; 12():235. PubMed ID: 26683050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cross-reactive idiotypy in cerebrospinal fluid immunoglobulins in multiple sclerosis.
    LaGanke CC; Freeman DW; Whitaker JN
    Ann Neurol; 2000 Jan; 47(1):87-92. PubMed ID: 10632105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Magnetic resonance imaging in multiple sclerosis: diagnostic value and clinical correlations.
    Milanese C; Savoiardo M; La Mantia L; Campi A; Visciani A; Salmaggi A; Tajoli Malesani L
    Ital J Neurol Sci; 1988 Apr; 9(2):127-34. PubMed ID: 3397265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immunoenzymatic determination of free immunoglobulin light chains in the cerebrospinal fluid: its value in the biological diagnosis of multiple sclerosis].
    Allal C; Ghaffor M; Rabhi H; Chaouche M; Tazir M; Abbadi MC
    Arch Inst Pasteur Alger; 1989; 57():111-24. PubMed ID: 2518740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The long march of the cerebrospinal fluid profile indicative of clinical definite multiple sclerosis; and still marching.
    Tourtellotte WW; Baumhefner RW; Syndulko K; Shapshak P; Osborne M; Rubinshtein G; Newton L; Ellison G; Myers L; Rosario I
    J Neuroimmunol; 1988 Dec; 20(2-3):217-27. PubMed ID: 3198746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The application of immunoblotting micromethod for the detection of oligoclonal Igg in cerebrospinal fluid in multiple sclerosis].
    Zaborski J; Fiszer U; Korlak J; Członkowska A
    Neurol Neurochir Pol; 1996; 30(1):17-27. PubMed ID: 8657347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sensitized immunofixation: a new technique for analyzing the oligoclonal pattern of CSF immunoglobulins].
    Desplat S; Pelletier J; Pouget J; Bellon F; Bernard D; Boucraut J
    Rev Neurol (Paris); 2000 Oct; 156(10):885-9. PubMed ID: 11033517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Progress of research in the diagnosis of multiple sclerosis by study of the cerebrospinal fluid].
    Schmidt RM; Kuppe G; Kissig B; Ludewig R; Neumann V
    Psychiatr Neurol Med Psychol (Leipz); 1987 Nov; 39(11):651-61. PubMed ID: 2450384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cerebrospinal fluid diagnosis of multiple sclerosis].
    Meyer-Rienecker H
    Psychiatr Neurol Med Psychol (Leipz); 1976 Nov; 28(11):641-53. PubMed ID: 65778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Intrathecal immunity in multiple sclerosis: comparison of quantitative and qualitative methods of analysis].
    Uldry PA; Steck AJ; Regli F
    Schweiz Arch Neurol Psychiatr (1985); 1989; 140(4):365-72. PubMed ID: 2477900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.